Elisabeth Leiderman Bluebird Bio, Inc. (BLUE) insider trading activity

Elisabeth Leiderman is of bluebird bio, Inc.. Currently has a direct ownership of 47,156 shares of BLUE, which is worth approximately $19,805. The most recent transaction as insider was on Nov 06, 2024, when has been sold 24,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.2K

111.88% 3M change

111.88% 12M change

Total Value Held $19,805

Elisabeth Leiderman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 06 2024	BUY Grant, award, or other acquisition	-	24,900 Added 34.56%	47,156 Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	10,790 Added 32.65%	22,256 Common Stock
Oct 17 2022	SELL Open market or private sale	$6,485 $6.46 p/Share	1,004 Reduced 8.05%	11,466 Common Stock
Jun 22 2022	BUY Grant, award, or other acquisition	-	3,109 Added 19.96%	12,470 Common Stock
Nov 11 2021	BUY Other acquisition or disposition	-	9,361 Added 50.0%	9,361 Common Stock
Oct 15 2021	BUY Grant, award, or other acquisition	-	4,663 Added 50.0%	4,663 Common Stock

Also insider at

DBTX

Decibel Therapeutics, Inc. Healthcare

Chief Financial Officer